Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 137th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
XRTX	XORTX THERAPEUTICS INC	$3.55M	-124.30%	-70.50%	-99.30%	-784.00%	0.23	3.53	N/A	N/A	N/A
CAPS	CAPSTONE HOLDING CORP	$9.13M	N/A	-11.00%	-1.84%	-2.10%	-6.76	1.02	21.30%	-12.20%	-1.42%
EVGN	EVOGENE LTD	$7.36M	-1,185.50%	-39.30%	-62.04%	-84.90%	-17.25	1.16	68.50%	-193.70%	-154.32%
DYAI	DYADIC INTERNATIONAL INC	$36.71M	-171.30%	-52.80%	-71.92%	-76.50%	3.02	4.02	65.80%	-166.20%	-153.95%
ADXN	ADDEX THERAPEUTICS LTD	$6.13M	92.00%	63.90%	49.69%	183.90%	0.10	4.59	100.00%	912.40%	946.32%
AFMD	AFFIMED NV	$16.31M	-193.90%	-107.30%	-302.86%	-162.40%	1.32	1.93	100.00%	-7,978.30%	-8,005.25%
ANEB	ANEBULO PHARMACEUTICALS INC	$49.71M	-119.50%	-108.10%	-49.65%	-2,927.60%	0.06	17.52	N/A	N/A	N/A
AKTX	AKARI THERAPEUTICS PLC	$83.16M	-956.20%	-129.50%	-63.77%	216.90%	1.28	0.15	N/A	N/A	N/A
ABP	ABPRO HOLDINGS INC	$12.48M	N/A	-296.80%	45.80%	192.60%	-1.27	0.19	100.00%	-9,513.10%	-3,740.44%
EPRX	EUPRAXIA PHARMACEUTICALS INC	$146.13M	-133.20%	-96.30%	-78.96%	657.50%	0.09	11.10	N/A	N/A	N/A
ZVSA	ZYVERSA THERAPEUTICS INC	$1.57M	-106.40%	-46.40%	-97.53%	-104.50%	1.42	0.15	N/A	N/A	N/A
IPA	IMMUNOPRECISE ANTIBODIES LTD	$14.39M	-148.10%	-82.10%	-139.08%	-174.50%	0.81	2.32	50.80%	-192.20%	-212.12%
TSVT	2SEVENTY BIO INC	$261.17M	-26.00%	-11.40%	-13.03%	-9.20%	1.28	4.67	52.40%	-151.20%	-151.20%
ACXP	ACURX PHARMACEUTICALS INC	$9.48M	-444.00%	-221.00%	-2,292.74%	468.30%	5.27	1.19	N/A	N/A	N/A
FGEN	FIBROGEN INC	$34.11M	N/A	-16.70%	-48.76%	-22.40%	-1.77	1.47	47.50%	-160.60%	-133.69%
ANL	ADLAI NORTYE LTD	$67.83M	N/A	-62.10%	-97.30%	420.70%	1.02	1.85	100.00%	-1,081.30%	-1,038.56%
ATNF	180 LIFE SCIENCES CORP	$4.62M	-488.40%	-185.40%	-69.27%	211.20%	0.38	1.47	N/A	N/A	N/A
APLM	APOLLOMICS INC	$7.27M	-233.70%	-157.30%	-937.36%	2,070.90%	1.69	1.39	N/A	N/A	N/A
EYEN	EYENOVIA INC	$3.17M	N/A	-278.20%	382.39%	-725.70%	-1.28	0.17	-6,749.50%	-86,888.60%	-82,555.47%
SONN	SONNET BIOTHERAPEUTICS HOLDINGS INC	$4.38M	-408.90%	-174.10%	-228.34%	1,586.30%	0.78	2.15	100.00%	-942.90%	-927.10%
EQ	EQUILLIUM INC	$14.96M	-37.60%	-22.00%	-40.04%	-94.00%	0.34	3.93	100.00%	-19.60%	-18.75%
ENTX	ENTERA BIO LTD	$98.56M	-119.50%	-102.00%	-115.98%	-21,776.00%	0.16	7.63	5.00%	-5,271.30%	-5,263.54%
EDSA	EDESA BIOTECH INC	$16.16M	-213.70%	-124.20%	-269.79%	574.30%	0.84	1.09	N/A	N/A	N/A
LYEL	LYELL IMMUNOPHARMA INC	$140.23M	-65.90%	-55.80%	-78.48%	-66.90%	0.28	7.06	100.00%	-562,285.20%	-562,285.25%
CVM	CEL SCI CORP	$22.39M	-238.10%	-104.70%	-134.65%	-100.30%	1.27	1.07	N/A	N/A	N/A
SLRN	ACELYRIN INC	$248.75M	-45.20%	-40.40%	-53.43%	-64.30%	0.07	18.10	N/A	N/A	N/A
ONCO	ONCONETIX INC	$605.52k	N/A	-72.70%	-113.09%	1,082.00%	0.62	0.06	-39.10%	-2,758.70%	-2,694.07%
ADAP	ADAPTIMMUNE THERAPEUTICS PLC	$71.40M	-133.30%	-24.80%	-35.21%	-50.50%	19.76	2.92	100.00%	-39.80%	-35.89%
LSB	LAKESHORE BIOPHARMA CO LTD	$228.97M	-41.10%	-15.70%	-31.61%	-21.60%	1.38	1.17	80.60%	-35.50%	-33.03%
ATHA	ATHIRA PHARMA INC	$11.01M	-132.60%	-99.50%	-212.38%	-2,613.80%	0.31	4.18	N/A	N/A	N/A
SNPX	SYNAPTOGENIX INC	$3.38M	-91.10%	-55.10%	-76.37%	704.30%	1.87	17.47	N/A	N/A	N/A
INM	INMED PHARMACEUTICALS INC	$3.59M	-90.70%	-71.70%	-112.57%	-327.30%	0.38	3.05	35.40%	-163.80%	-156.35%
IBO	IMPACT BIOMEDICAL INC	$5.16M	-118.70%	-63.60%	-224.75%	-1,464.40%	3.07	0.25	N/A	N/A	N/A
BRNS	BARINTHUS BIOTHERAPEUTICS PLC	$45.18M	-39.50%	-33.20%	-42.21%	-186.80%	0.23	8.03	100.00%	-408.00%	-407.94%
ESLA	ESTRELLA IMMUNOPHARMA INC	$39.06M	-259.10%	-177.30%	-6,154.51%	-1,725.00%	20.85	0.55	N/A	N/A	N/A
ENSC	ENSYSCE BIOSCIENCES INC	$4.24M	-197.50%	-139.80%	-197.53%	-639.90%	0.60	2.42	N/A	N/A	N/A
CMND	CLEARMIND MEDICINE INC	$4.74M	-140.90%	-64.30%	-165.80%	130.90%	1.31	1.72	N/A	N/A	N/A
CGTX	COGNITION THERAPEUTICS INC	$26.46M	-159.70%	-103.70%	-177.80%	644.90%	0.61	2.65	N/A	N/A	N/A
RLYB	RALLYBIO CORP	$13.32M	-76.60%	-68.20%	-93.39%	-101.30%	0.11	10.87	100.00%	-9,084.10%	-9,084.12%
LSTA	LISATA THERAPEUTICS INC	$20.43M	-55.30%	-48.70%	-70.72%	-145.30%	0.19	6.16	100.00%	-1,998.50%	-2,078.30%
DRTS	ALPHA TAU MEDICAL LTD	$180.17M	-44.50%	-33.80%	-35.40%	-29.80%	0.38	7.40	N/A	N/A	N/A
CHRO	CHANNEL THERAPEUTICS CORP	$6.96M	N/A	-313.70%	264.14%	564.90%	-1.50	0.34	N/A	N/A	N/A
ELEV	ELEVATION ONCOLOGY INC	$22.03M	-62.20%	-41.80%	-47.43%	-60.40%	0.59	21.21	N/A	N/A	N/A
CDIO	CARDIO DIAGNOSTICS HOLDINGS INC	$22.16M	-173.30%	-143.20%	-83.79%	-343.10%	0.11	13.92	100.00%	-24,028.20%	-23,974.82%
CRIS	CURIS INC	$17.91M	N/A	-88.50%	-195.11%	-869.00%	-7.88	1.39	99.10%	-397.80%	-397.77%
BOLT	BOLT BIOTHERAPEUTICS INC	$13.61M	-79.10%	-53.00%	-75.34%	-55.20%	0.74	3.21	100.00%	-820.80%	-820.78%
CASI	CASI PHARMACEUTICALS INC	$30.06M	-301.80%	-60.90%	-222.90%	-95.50%	28.00	1.09	39.10%	-137.60%	-134.52%
TVRD	TVARDI THERAPEUTICS INC	$114.07M	-755.60%	-110.00%	-157.55%	-112.60%	-10.54	11.03	91.30%	-993.00%	-879.81%
CNTB	CONNECT BIOPHARMA HOLDINGS LTD	$45.50M	-16.20%	-13.80%	-16.60%	-286.90%	0.10	11.46	100.00%	-60.00%	-59.17%
CYCN	CYCLERION THERAPEUTICS INC	$9.35M	-34.20%	-30.60%	-34.54%	-63.10%	0.08	5.83	100.00%	-152.80%	-152.85%
EXOZ	EXOZYMES INC	$92.05M	-708.90%	-95.10%	-50.76%	-173.00%	0.25	8.12	N/A	N/A	N/A
CLGN	COLLPLANT BIOTECHNOLOGIES LTD	$24.28M	-87.90%	-67.80%	-109.60%	-246.30%	0.39	4.44	-215.50%	-3,225.00%	-3,349.71%
CMMB	CHEMOMAB THERAPEUTICS LTD	$25.46M	-104.90%	-79.20%	-101.45%	-169.60%	0.25	4.98	N/A	N/A	N/A
DARE	DARE BIOSCIENCE INC	$26.11M	N/A	-21.10%	-823.70%	48.80%	-4.68	0.85	100.00%	-41,430.90%	-41,430.90%
BOLD	BOUNDLESS BIO INC	$39.25M	-73.90%	-38.10%	-32.97%	-45.60%	0.37	18.98	N/A	N/A	N/A
CNTX	CONTEXT THERAPEUTICS INC	$77.77M	-37.00%	-35.80%	-28.02%	7,273.10%	0.03	35.62	N/A	N/A	N/A
CYCC	CYCLACEL PHARMACEUTICALS INC	$53.49M	N/A	-188.20%	551.70%	249.70%	-2.88	0.59	100.00%	-26,074.40%	-27,893.02%
CKPT	CHECKPOINT THERAPEUTICS INC	$344.27M	N/A	-742.60%	445.47%	285.80%	-1.59	0.37	100.00%	-137,170.70%	-137,170.73%
INTS	INTENSITY THERAPEUTICS INC	$8.93M	-313.40%	-209.40%	-537.25%	-1,143.00%	0.64	1.92	N/A	N/A	N/A
COCP	COCRYSTAL PHARMA INC	$15.36M	-112.60%	-90.00%	-158.72%	-565.40%	0.41	4.77	N/A	N/A	N/A
BRTX	BIORESTORATIVE THERAPIES INC	$13.21M	-82.00%	-59.00%	-105.25%	-99.80%	0.44	2.97	93.00%	-2,239.20%	-2,239.25%
ERNA	ETERNA THERAPEUTICS INC	$10.81M	N/A	-163.30%	-1,619.78%	-81.80%	2.10	0.80	83.50%	-7,655.50%	-6,487.46%
GTBP	GT BIOPHARMA INC	$5.41M	-468.10%	-174.50%	788.14%	502.50%	-3.53	0.72	N/A	N/A	N/A
ENTO	ENTERO THERAPEUTICS INC	$1.63M	-245.70%	-21.00%	-31.21%	-27.70%	-7.12	3.03	N/A	N/A	N/A
GBIO	GENERATION BIO CO	$29.01M	-120.20%	-51.10%	-67.13%	-47.30%	1.68	5.50	100.00%	-661.90%	-661.91%
HCWB	HCW BIOLOGICS INC	$9.05M	N/A	-105.30%	-4,836.76%	-228.40%	-5.47	0.19	100.00%	-3,129.40%	-3,063.64%
CAMP	CAMP4 THERAPEUTICS CORP	$35.69M	N/A	-77.70%	-75.38%	-333.10%	0.24	6.92	100.00%	-7,943.40%	-7,943.40%
BLRX	BIOLINERX LTD	$15.49M	-75.30%	-17.70%	-0.43%	-1.70%	1.89	1.76	68.00%	-31.90%	-0.35%
ICCC	IMMUCELL CORP	$48.69M	-8.50%	-4.90%	-5.28%	-4.10%	0.64	3.41	30.00%	-8.10%	-8.10%
GNPX	GENPREX INC	$7.00M	-522.10%	-314.50%	-1,303.03%	-4,612.40%	1.55	0.83	N/A	N/A	N/A
BCAB	BIOATLA INC	$28.38M	-235.90%	-102.40%	-184.19%	690.60%	2.68	3.52	100.00%	-634.30%	-634.33%
BHST	BIOHARVEST SCIENCES INC	$111.59M	-574.70%	-56.90%	-65.06%	-37.70%	17.80	0.55	55.40%	-51.30%	-27.75%
CARM	CARISMA THERAPEUTICS INC	$8.32M	N/A	-117.60%	-419.89%	-942.70%	-2.09	1.48	100.00%	-308.10%	-308.05%
BCLI	BRAINSTORM CELL THERAPEUTICS INC	$8.48M	N/A	-360.70%	161.57%	251.60%	-1.24	0.04	N/A	N/A	N/A
SILO	SILO PHARMA INC	$3.36M	-76.20%	-56.80%	-76.23%	-187.00%	0.47	4.29	91.90%	-6,092.60%	-6,085.54%
SLGL	SOL-GEL TECHNOLOGIES LTD	$21.17M	-32.30%	-26.30%	-34.62%	-53.40%	0.24	5.92	100.00%	-91.70%	-91.70%
CLRB	CELLECTAR BIOSCIENCES INC	$11.61M	-262.20%	-132.00%	-276.73%	375.30%	0.69	2.58	N/A	N/A	N/A
AVTE	AEROVATE THERAPEUTICS INC	$77.68M	-60.00%	-54.30%	-65.11%	-103.60%	0.03	32.01	N/A	N/A	N/A
IMMX	IMMIX BIOPHARMA INC	$58.49M	-104.70%	-77.70%	-151.27%	-59,867.00%	0.73	2.33	N/A	N/A	N/A
AZTR	AZITRA INC	$4.84M	-181.10%	-132.40%	-149.53%	-475.80%	0.29	3.80	100.00%	-119,566.60%	-119,284.01%
LVTX	LAVA THERAPEUTICS NV	$32.88M	-65.10%	-28.30%	-38.15%	-53.60%	1.91	4.40	100.00%	-209.60%	-200.04%
CALC	CALCIMEDICA INC	$21.17M	-100.50%	-65.10%	-85.04%	-138.30%	0.37	5.34	N/A	N/A	N/A
BYSI	BEYONDSPRING INC	$70.15M	N/A	-37.60%	-47.32%	-91.60%	-1.48	2.60	N/A	N/A	N/A
BCDA	BIOCARDIA INC	$14.70M	N/A	-204.30%	-566.36%	1,041.40%	3.45	1.13	100.00%	-13,700.00%	-13,700.00%
KTTA	PASITHEA THERAPEUTICS CORP	$4.49M	-81.00%	-74.40%	-93.04%	2,379.10%	0.09	6.58	N/A	N/A	N/A
ARTL	ARTELO BIOSCIENCES INC	$3.22M	-150.90%	-128.80%	-335.82%	-396.20%	0.64	1.44	N/A	N/A	N/A
ARMP	ARMATA PHARMACEUTICALS INC	$57.53M	N/A	-18.30%	-21.40%	-7.00%	-2.80	0.23	100.00%	-365.60%	-157.98%
APM	APTORUM GROUP LTD	$5.27M	-18.60%	-23.20%	-34.95%	-24.30%	0.21	0.22	N/A	N/A	N/A
MOLN	MOLECULAR PARTNERS AG	$143.77M	-35.80%	-32.30%	-36.55%	-58.10%	0.12	14.31	100.00%	-1,087.40%	-1,086.58%
APLT	APPLIED THERAPEUTICS INC	$57.90M	-208.60%	-89.50%	-177.83%	179.90%	0.52	3.06	100.00%	-23,214.10%	-23,214.07%
SRZN	SURROZEN INC	$36.13M	-1,241.20%	-142.60%	-154.46%	-743.00%	-3.27	5.32	100.00%	-596.60%	-596.56%
ANTX	AN2 THERAPEUTICS INC	$37.32M	-54.20%	-48.90%	-62.70%	-75.40%	0.13	8.43	N/A	N/A	N/A
ADIL	ADIAL PHARMACEUTICALS INC	$4.54M	-259.40%	-225.70%	-324.41%	-1,720.70%	0.24	4.16	N/A	N/A	N/A
ALZN	ALZAMEND NEURO INC	$4.35M	-504.20%	-149.10%	-121.98%	316.10%	0.21	5.44	N/A	N/A	N/A
APRE	APREA THERAPEUTICS INC	$9.56M	-54.10%	-45.50%	-69.10%	609.80%	0.24	7.02	100.00%	-862.40%	-948.23%
MNOV	MEDICINOVA INC	$74.55M	-19.70%	-18.60%	-20.87%	-294.20%	0.06	13.88	N/A	N/A	N/A
PBM	PSYENCE BIOMEDICAL LTD	$1.78M	N/A	-583.50%	465.76%	5,423.00%	-1.10	0.09	N/A	N/A	N/A
ALLK	ALLAKOS INC	$29.41M	-136.40%	-83.50%	-155.13%	-106.00%	0.23	4.81	N/A	N/A	N/A
PPBT	PURPLE BIOTECH LTD	$124.11M	23.60%	19.60%	23.37%	-189.50%	0.13	2.23	N/A	N/A	N/A
ADAG	ADAGENE INC	$71.61M	-55.20%	-32.60%	-63.80%	343.60%	0.77	2.30	100.00%	-32,386.40%	-31,578.03%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in May 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Protalix Biotherapeutics (NYSEMKT:PLX)

Protalix Biotherapeutics (NYSEMKT:PLX) is the #1 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Protalix Biotherapeutics (NYSEMKT:PLX) is: Value: B, Growth: A, Momentum: B, Sentiment: A, Safety: C, Financials: B, and AI: A.

Protalix Biotherapeutics (NYSEMKT:PLX) has a Due Diligence Score of 23, which is -1 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates PLX as a "A".

PLX passed 7 out of 33 due diligence checks and has weak fundamentals. Protalix Biotherapeutics has seen its stock return 169.3% over the past year, overperforming other biotech stocks by 246 percentage points.

Protalix Biotherapeutics has an average 1 year price target of $15.00, an upside of 388.6% from Protalix Biotherapeutics's current stock price of $3.07.

Protalix Biotherapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Protalix Biotherapeutics, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)

Aurinia Pharmaceuticals (NASDAQ:AUPH) is the #2 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aurinia Pharmaceuticals (NASDAQ:AUPH) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: C.

Aurinia Pharmaceuticals (NASDAQ:AUPH) has a Due Diligence Score of 57, which is 33 points higher than the biotech industry average of 24.

AUPH passed 19 out of 33 due diligence checks and has strong fundamentals. Aurinia Pharmaceuticals has seen its stock return 61.89% over the past year, overperforming other biotech stocks by 139 percentage points.

3. Catalyst Pharmaceuticals (NASDAQ:CPRX)

Catalyst Pharmaceuticals (NASDAQ:CPRX) is the #3 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Catalyst Pharmaceuticals (NASDAQ:CPRX) is: Value: A, Growth: C, Momentum: C, Sentiment: A, Safety: D, Financials: A, and AI: B.

Catalyst Pharmaceuticals (NASDAQ:CPRX) has a Due Diligence Score of 76, which is 52 points higher than the biotech industry average of 24.

CPRX passed 25 out of 33 due diligence checks and has strong fundamentals. Catalyst Pharmaceuticals has seen its stock return 61.4% over the past year, overperforming other biotech stocks by 138 percentage points.

Catalyst Pharmaceuticals has an average 1 year price target of $33.20, an upside of 36.68% from Catalyst Pharmaceuticals's current stock price of $24.29.

Catalyst Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Catalyst Pharmaceuticals, 60% have issued a Strong Buy rating, 40% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 6.97%, which is 5 percentage points higher than the biotech industry average of 1.92%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 2.43%, which is 1 percentage points higher than the biotech industry average of 1.92%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 45.5% indicates that its dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.31%, which is -1 percentage points lower than the biotech industry average of 1.92%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 43.8% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 1.74% in the last day, and up 4.52% over the last week. Regulus Therapeutics was the among the top gainers in the biotechnology industry, gaining 136.8% yesterday.

Regulus Therapeutics shares are trading higher after the company announced it entered into an agreement to be acquired by Novartis AG for $7 in cash per share.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -4.66% in the past year. It has overperformed other stocks in the biotech industry by 72 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has dropped -37.28% in the past year. It has overperformed other stocks in the biotech industry by 40 percentage points.

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 5.61% in the past year. It has overperformed other stocks in the biotech industry by 82 percentage points.

Are biotech stocks a good buy now?

54.79% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 100.94% over the next year.

1.74% of biotech stocks have a Zen Rating of A (Strong Buy), 4.14% of biotech stocks are rated B (Buy), 42.05% are rated C (Hold), 36.38% are rated D (Sell), and 15.69% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -162.28x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.